Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures
Open Access
- 6 March 2018
- journal article
- review article
- Published by Springer Science and Business Media LLC in Molecular Psychiatry
- Vol. 24 (4), 549-561
- https://doi.org/10.1038/s41380-018-0041-5
Abstract
Although synaptic loss is thought to be core to the pathophysiology of schizophrenia, the nature, consistency and magnitude of synaptic protein and mRNA changes has not been systematically appraised. Our objective was thus to systematically review and meta-analyse findings. The entire PubMed database was searched for studies from inception date to the 1st of July 2017. We selected case-control postmortem studies in schizophrenia quantifying synaptic protein or mRNA levels in brain tissue. The difference in protein and mRNA levels between cases and controls was extracted and meta-analysis conducted. Among the results, we found a significant reduction in synaptophysin in schizophrenia in the hippocampus (effect size: −0.65, p < 0.01), frontal (effect size: −0.36, p = 0.04), and cingulate cortices (effect size: −0.54, p = 0.02), but no significant changes for synaptophysin in occipital and temporal cortices, and no changes for SNAP-25, PSD-95, VAMP, and syntaxin in frontal cortex. There were insufficient studies for meta-analysis of complexins, synapsins, rab3A and synaptotagmin and mRNA measures. Findings are summarised for these, which generally show reductions in SNAP-25, PSD-95, synapsin and rab3A protein levels in the hippocampus but inconsistency in other regions. Our findings of moderate–large reductions in synaptophysin in hippocampus and frontal cortical regions, and a tendency for reductions in other pre- and postsynaptic proteins in the hippocampus are consistent with models that implicate synaptic loss in schizophrenia. However, they also identify potential differences between regions and proteins, suggesting synaptic loss is not uniform in nature or extent.Keywords
This publication has 148 references indexed in Scilit:
- Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studiesTranslational Psychiatry, 2012
- Abnormal Activity of the MAPK- and cAMP-Associated Signaling Pathways in Frontal Cortical Areas in Postmortem Brain in SchizophreniaNeuropsychopharmacology, 2011
- Synapsin III: Role in neuronal plasticity and diseaseSeminars in Cell & Developmental Biology, 2011
- Lack of Change in Markers of Presynaptic Terminal Abundance Alongside Subtle Reductions in Markers of Presynaptic Terminal Plasticity in Prefrontal Cortex of Schizophrenia PatientsBiological Psychiatry, 2011
- Altered Cortical CDC42 Signaling Pathways in Schizophrenia: Implications for Dendritic Spine DeficitsBiological Psychiatry, 2010
- Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depressionSchizophrenia Research, 2010
- Panel of synaptic protein ELISAs for evaluating neurological phenotypeExperimental Brain Research, 2010
- Are the Dorsal and Ventral Hippocampus Functionally Distinct Structures?Neuron, 2010
- A critical role for PSD-95/AKAP interactions in endocytosis of synaptic AMPA receptorsNature Neuroscience, 2009
- Reduced Dendritic Spine Density in Auditory Cortex of Subjects with SchizophreniaNeuropsychopharmacology, 2008